- Home
- BLIN vs MIRA Comparison
BLIN vs MIRA Comparison
Compare BLIN & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- MIRA
- Stock Information
- Founded
- BLIN 2000
- MIRA 2020
- Country
- BLIN United States
- MIRA United States
- Employees
- BLIN N/A
- MIRA N/A
- Industry
- BLIN EDP Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BLIN Technology
- MIRA Health Care
- Exchange
- BLIN Nasdaq
- MIRA Nasdaq
- Market Cap
- BLIN 16.5M
- MIRA 19.5M
- IPO Year
- BLIN 2007
- MIRA 2023
- Fundamental
- Price
- BLIN $1.46
- MIRA $1.82
- Analyst Decision
- BLIN Strong Buy
- MIRA Strong Buy
- Analyst Count
- BLIN 1
- MIRA 2
- Target Price
- BLIN $4.62
- MIRA $14.00
- AVG Volume (30 Days)
- BLIN 35.7K
- MIRA 3.4M
- Earning Date
- BLIN 08-13-2025
- MIRA 08-12-2025
- Dividend Yield
- BLIN N/A
- MIRA N/A
- EPS Growth
- BLIN N/A
- MIRA N/A
- EPS
- BLIN N/A
- MIRA N/A
- Revenue
- BLIN $15,465,000.00
- MIRA N/A
- Revenue This Year
- BLIN $4.08
- MIRA N/A
- Revenue Next Year
- BLIN $12.95
- MIRA N/A
- P/E Ratio
- BLIN N/A
- MIRA N/A
- Revenue Growth
- BLIN 1.30
- MIRA N/A
- 52 Week Low
- BLIN $0.76
- MIRA $0.62
- 52 Week High
- BLIN $2.80
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- BLIN 42.14
- MIRA 76.83
- Support Level
- BLIN $1.35
- MIRA $1.07
- Resistance Level
- BLIN $1.52
- MIRA $2.09
- Average True Range (ATR)
- BLIN 0.06
- MIRA 0.17
- MACD
- BLIN 0.00
- MIRA 0.09
- Stochastic Oscillator
- BLIN 36.84
- MIRA 86.27
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.